Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjects

Clin Endocrinol (Oxf). 2019 Aug;91(2):278-287. doi: 10.1111/cen.14007. Epub 2019 May 15.

Abstract

Objective: Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine disorder associated with mitochondrial dysfunction and insulin resistance (IR). MOTS-c, a mitochondrial peptide, promotes insulin sensitivity (IS) through activating AKT and AMPK-dependent pathways. The current study was designed to examine the response of MOTS-c to lipids (intralipid) followed by insulin in PCOS and healthy subjects.

Methods: All subjects underwent 5-hour intralipid/saline infusion with a hyperinsulinemic-euglycaemic clamp in the final 2 hours. Plasma samples were collected to measure circulating MOTS-c using a commercial ELISA kit. Subsequently, this was repeated following an eight-week exercise intervention.

Results: Intralipid significantly increased plasma MOTS-c both in controls and PCOS subjects, whilst the insulin infusion blunted the intralipid-induced response seen for both lipids and MOT-c. Intralipid elevated plasma MOTS-c to 232 ± 124% of basal in control (P < 0.01) and to 349 ± 206% of basal in PCOS (P < 0.001) subjects. Administration of insulin suppressed intralipid-induced MOTS-c from 232 ± 124% to 165 ± 97% (NS) in control and from 349 ± 206% to 183 ± 177% (P < 0.05) in PCOS subjects, respectively. Following exercise, intralipid elevated plasma MOTS-c to 305 ± 153% of basal in control (P < 0.01) and to 215 ± 103% of basal in PCOS (P < 0.01) subjects; insulin suppressed intralipid-induced MOTS-c only in controls.

Conclusions: In conclusion, this is the first study to show increased lipid enhanced circulating MOTS-c whilst insulin attenuated the MOTS-c response in human. Further, eight weeks of moderate exercise training did not show any changes in circulating MOTS-c levels in healthy controls and in women with PCOS.

Keywords: metabolic syndrome; mitochondrial dysfunction; mitochondrial open reading frame of the 12S rRNA type-c; polycystic ovarian syndrome; triglycerides and insulin resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Emulsions / administration & dosage
  • Emulsions / pharmacology
  • Enzyme-Linked Immunosorbent Assay / methods
  • Exercise / physiology
  • Female
  • Glucose Clamp Technique / methods
  • Healthy Volunteers / statistics & numerical data*
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / pharmacology
  • Infusions, Intravenous
  • Insulin / administration & dosage
  • Insulin / pharmacology*
  • Mitochondrial Proteins / blood*
  • Phospholipids / administration & dosage
  • Phospholipids / pharmacology*
  • Polycystic Ovary Syndrome / blood*
  • Polycystic Ovary Syndrome / diagnosis
  • Polycystic Ovary Syndrome / physiopathology
  • Soybean Oil / administration & dosage
  • Soybean Oil / pharmacology*
  • Young Adult

Substances

  • Emulsions
  • Hypoglycemic Agents
  • Insulin
  • MOTS-c peptide, human
  • Mitochondrial Proteins
  • Phospholipids
  • soybean oil, phospholipid emulsion
  • Soybean Oil

Associated data

  • ISRCTN/ISRCTN42448814